Jozef Bartunek

Showing 1-11 of 11 articles

Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial

Pellicano M, Di Gioia G, Ciccarelli G, Xaplanteris P, Delrue L, Toth G, Van Durme F, Heyse A, Wyffels E, Vanderheyden M, Bartunek J, De Bruyne B, Barbato E

June 12, 2020 | 10.4244/EIJ-D-18-01138

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou C, Özdemir R, Pfister R, Bergmann M, Bartunek J, Kilic T, Lauten A, Schmeisser A, Zoghi M, Anker S, Sievert H, Mahfoud F

August 29, 2019 | 10.4244/EIJ-D-19-00342

Coronary interventions

Plaque protrusion compromising bioresorbable coronary scaffold patency

Flore V, Pellicano M, Adjedj J, Ferrara A, Van Der Steen K, Bartunek J

September 18, 2016 | 10.4244/EIJV12I7A142

Coronary interventions

Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study

Verheye S, Khattab A, Carrié D, Stella P, Slagboom T, Bartunek J, Onuma Y, Serruys P

August 5, 2016 | 10.4244/EIJV12I5A101

Influence of transradial versus transfemoral diagnostic heart catheterisation on peripheral vascular endothelial function

Di Serafino L, Pyxaras S, Mangiacapra F, Dierickx K, Toth G, Bartunek J, De Bruyne B, Van Mieghem C, Wijns W, Barbato E

March 22, 2013 | 10.4244/EIJV8I11A193

Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction

Mueller O, Delrue L, Hamilos M, Vercauteren S, Ntalianis A, Trana C, Mangiacapra F, Dierickx K, De Bruyne B, Wijns W, Behfar A, Barbato E, Terzic A, Vanderheyden M, Bartunek J

August 30, 2011 | 10.4244/EIJV7I4A75

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

Duckers H, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A, Bartunek J, Nienaber C, Naber C, Macaya C, Peters N, Smits P, Siminiak T, van Mieghem W, Legrand V, Serruys P

February 21, 2011

Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis

Melikian N, Vercauteren S, Fearon W, Cuisset T, MacCarthy P, Davidavicius G, Aarnoudse W, Bartunek J, Vanderheyden M, Wyffels E, Wijns W, Heyndrickx G, Pijls N, De Bruyne B

April 12, 2010

The recurrence of iatrogenic femoral artery pseudoaneurysm after occlusion by ultrasound guided percutaneous thrombin injection

Madaric J, Mistrik A, Vulev I, Liska B, Vozar M, Lederer P, Gocar M, Kozlovska T, Fridrich V, De Bruyne B, Bartunek J

September 30, 2009

Bone marrow mesenchymal stem cells and cardiac regeneration

Bartunek J, Hill J, Behfar A, Wijns W, Vanderheyden M, Willemsen P, de Lavareille A, Faber B, Heyndrickx G, Terzic A

May 22, 2007

Framework towards optimisation of bone marrow stem cells therapy for cardiac repair

Vanderheyden M, Heyndrickx G, Wijns W, Bartunek J

May 22, 2007

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease